Index by Author

May 2003; 26 (5)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Abramovitch, Yehuda

    • Effect of Acute Psychotic Stress in Nondiabetic Subjects on β-Cell Function and Insulin Sensitivity Diabetes Care May 2003 26:1462-1467; doi:10.2337/diacare.26.5.1462

  2. Adachi, Yukihiko

    • Increased Oxidative Stress Is Associated With Elevated Plasma Levels of Adrenomedullin in Hypertensive Patients With Type 2 Diabetes Diabetes Care May 2003 26:1642-1643; doi:10.2337/diacare.26.5.1642

  3. Agarwal, Anil K.

    • Risk Factors for Diabetes in Familial Partial Lipodystrophy, Dunnigan Variety Diabetes Care May 2003 26:1350-1355; doi:10.2337/diacare.26.5.1350

  4. Aguilar-Salinas, Carlos A.

    • Analysis of the Agreement Between the World Health Organization Criteria and the National Cholesterol Education Program-III Definition of the Metabolic Syndrome: Results from a population-based survey Diabetes Care May 2003 26:1635; doi:10.2337/diacare.26.5.1635

  5. Alter, David A.

    • Processes and Outcomes of Care for Diabetic Acute Myocardial Infarction Patients in Ontario: Do physicians undertreat? Diabetes Care May 2003 26:1427-1434; doi:10.2337/diacare.26.5.1427

  6. Amad, Hani

    • Diabetes and Coronary Artery Bypass Surgery: An examination of perioperative glycemic control and outcomes Diabetes Care May 2003 26:1518-1524; doi:10.2337/diacare.26.5.1518

  7. Amin, Rakesh

    • Low IGF-I and Elevated Testosterone During Puberty in Subjects With Type 1 Diabetes Developing Microalbuminuria in Comparison to Normoalbuminuric Control Subjects: The Oxford Regional Prospective Study Diabetes Care May 2003 26:1456-1461; doi:10.2337/diacare.26.5.1456

  8. Andersen, Steen

    • Long-Term Renoprotective Effects of Losartan in Diabetic Nephropathy: Interaction with ACE insertion/deletion genotype? Diabetes Care May 2003 26:1501-1506; doi:10.2337/diacare.26.5.1501

  9. Anderson, Gerard F.

  10. Anderson, James W.

    • Insulin Resistance and Cardiovascular Events With Low HDL Cholesterol: The Veterans Affairs HDL Intervention Trial (VA-HIT) Diabetes Care May 2003 26:1513-1517; doi:10.2337/diacare.26.5.1513

  11. Anderson, Robert M.

    • The Diabetes Empowerment Scale-Short Form (DES-SF) Diabetes Care May 2003 26:1641-1642; doi:10.2337/diacare.26.5.1641-a

  12. Andreotti, Felicita

    • IGF-1 and Macrovascular Complications of Diabetes: Alternative interpretations of recently published data Diabetes Care May 2003 26:1653-1654; doi:10.2337/diacare.26.5.1653

  13. Andrews, Roxanne

  14. Appel, Gerald B.

    • Analysis of Metabolic Parameters as Predictors of Risk in the RENAAL Study Diabetes Care May 2003 26:1402-1407; doi:10.2337/diacare.26.5.1402

  15. Araki, Eiichi

    • Evaluation of Urinary 8-Hydroxydeoxy-Guanosine as a Novel Biomarker of Macrovascular Complications in Type 2 Diabetes Diabetes Care May 2003 26:1507-1512; doi:10.2337/diacare.26.5.1507

  16. Armstrong, David G.

    • Diabetic Foot Syndrome: Evaluating the prevalence and incidence of foot pathology in Mexican Americans and non-Hispanic whites from a diabetes disease management cohort Diabetes Care May 2003 26:1435-1438; doi:10.2337/diacare.26.5.1435

  17. Atillasoy, Ercem S.

    • Dermatophyte Test Medium Culture for Evaluating Toenail Infections in Patients With Diabetes Diabetes Care May 2003 26:1480-1484; doi:10.2337/diacare.26.5.1480

  18. Austin, Peter C.

    • Processes and Outcomes of Care for Diabetic Acute Myocardial Infarction Patients in Ontario: Do physicians undertreat? Diabetes Care May 2003 26:1427-1434; doi:10.2337/diacare.26.5.1427

  19. Avram, Morrell M.

    • Analysis of Metabolic Parameters as Predictors of Risk in the RENAAL Study Diabetes Care May 2003 26:1402-1407; doi:10.2337/diacare.26.5.1402

B

  1. Badioli, Letizia

    • Effects of an Automated Electronic Reminder in Changing the Antiplatelet Drug–Prescribing Behavior Among Italian General Practitioners in Diabetic Patients: An intervention trial Diabetes Care May 2003 26:1497-1500; doi:10.2337/diacare.26.5.1497

  2. Ballantyne, Christie M.

    • Detection of Undiagnosed Diabetes and Other Hyperglycemia States: The Atherosclerosis Risk in Communities Study Diabetes Care May 2003 26:1338-1343; doi:10.2337/diacare.26.5.1338

  3. Barbieri, Michelangela

    • Cytokine Milieu Tends Toward Inflammation in Type 2 Diabetes Diabetes Care May 2003 26:1647; doi:10.2337/diacare.26.5.1647

  4. Bartoli, Ettore

    • The Significance of Impaired Fasting Glucose Versus Impaired Glucose Tolerance: Importance of insulin secretion and resistance Diabetes Care May 2003 26:1333-1337; doi:10.2337/diacare.26.5.1333

  5. Becker, Dorothy J.

    • Insulin Resistance–Related Factors, but not Glycemia, Predict Coronary Artery Disease in Type 1 Diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications study Diabetes Care May 2003 26:1374-1379; doi:10.2337/diacare.26.5.1374

  6. Bergstrom, Richard W.

  7. Berman, Dora M.

    • Visceral Adipose Tissue Cutoffs Associated With Metabolic Risk Factors for Coronary Heart Disease in Women Diabetes Care May 2003 26:1413-1420; doi:10.2337/diacare.26.5.1413

  8. Biesenbach, Georg

    • The True Overall Mortality of Unselected Nephropathic Type 2 Diabetic Patients With Mild to Moderate Renal Insufficiency Diabetes Care May 2003 26:1639-1640; doi:10.2337/diacare.26.5.1639

  9. Bistritz, Lana

    • Diabetes and Coronary Artery Bypass Surgery: An examination of perioperative glycemic control and outcomes Diabetes Care May 2003 26:1518-1524; doi:10.2337/diacare.26.5.1518

  10. Blom, Henk J.

    • Improved Insulin Sensitivity and Metabolic Control in Type 2 Diabetes Does Not Influence Plasma Homocysteine Diabetes Care May 2003 26:1637-1639; doi:10.2337/diacare.26.5.1637

  11. Bloomgarden, Zachary T.

  12. Bolli, Geremia B.

    • Intensive Replacement of Basal Insulin in Patients With Type 1 Diabetes Given Rapid-Acting Insulin Analog at Mealtime: A 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime Diabetes Care May 2003 26:1490-1496; doi:10.2337/diacare.26.5.1490

  13. Boskovic, Rada

    • Transfer of Insulin Lispro Across the Human Placenta: In vitro perfusion studies Diabetes Care May 2003 26:1390-1394; doi:10.2337/diacare.26.5.1390

  14. Boulton, Andrew J.M.

    • Diabetic Foot Syndrome: Evaluating the prevalence and incidence of foot pathology in Mexican Americans and non-Hispanic whites from a diabetes disease management cohort Diabetes Care May 2003 26:1435-1438; doi:10.2337/diacare.26.5.1435

  15. Bouter, Lex M.

    • Prospective Relation of C-Reactive Protein With Type 2 Diabetes: Response to Han et al. Diabetes Care May 2003 26:1656-1657; doi:10.2337/diacare.26.5.1656

  16. Bowcock, Anne M.

    • Risk Factors for Diabetes in Familial Partial Lipodystrophy, Dunnigan Variety Diabetes Care May 2003 26:1350-1355; doi:10.2337/diacare.26.5.1350

  17. Brancati, Frederick

    • Detection of Undiagnosed Diabetes and Other Hyperglycemia States: The Atherosclerosis Risk in Communities Study Diabetes Care May 2003 26:1338-1343; doi:10.2337/diacare.26.5.1338

  18. Braunstein, Joel B.

  19. Brenner, Barry M.

    • Analysis of Metabolic Parameters as Predictors of Risk in the RENAAL Study Diabetes Care May 2003 26:1402-1407; doi:10.2337/diacare.26.5.1402

  20. Broch, Montserrat

    • Insulin Resistance, Inflammation, and Serum Fatty Acid Composition Diabetes Care May 2003 26:1362-1368; doi:10.2337/diacare.26.5.1362

  21. Brown, Anne

    • Glycemic Relapse After an Intensive Outpatient Intervention for Type 2 Diabetes Diabetes Care May 2003 26:1645-1646; doi:10.2337/diacare.26.5.1645

  22. Bruno, Graziella

    • Prevalence of Type 1 Diabetes-Related Autoantibodies in Adults With Celiac Disease Diabetes Care May 2003 26:1644-1645; doi:10.2337/diacare.26.5.1644

  23. Buchanan, Thomas A.

    • C-Reactive Protein and Glycemic Control in Adults With Diabetes Diabetes Care May 2003 26:1535-1539; doi:10.2337/diacare.26.5.1535

  24. Buchs, Andreas

    • Effect of Acute Psychotic Stress in Nondiabetic Subjects on β-Cell Function and Insulin Sensitivity Diabetes Care May 2003 26:1462-1467; doi:10.2337/diacare.26.5.1462

  25. Burgess, Ellen

    • Analysis of Metabolic Parameters as Predictors of Risk in the RENAAL Study Diabetes Care May 2003 26:1402-1407; doi:10.2337/diacare.26.5.1402

  26. Buse, John B.

C

  1. Cambien, Francois

    • Long-Term Renoprotective Effects of Losartan in Diabetic Nephropathy: Interaction with ACE insertion/deletion genotype? Diabetes Care May 2003 26:1501-1506; doi:10.2337/diacare.26.5.1501

  2. Campos, M.M.

    • Analysis of Metabolic Parameters as Predictors of Risk in the RENAAL Study Diabetes Care May 2003 26:1402-1407; doi:10.2337/diacare.26.5.1402

  3. Capoluongo, Ettore

    • IGF-1 and Macrovascular Complications of Diabetes: Alternative interpretations of recently published data Diabetes Care May 2003 26:1653-1654; doi:10.2337/diacare.26.5.1653

  4. Caputo, Francesco

  5. Carnevale Schianca, Gian Piero

    • The Significance of Impaired Fasting Glucose Versus Impaired Glucose Tolerance: Importance of insulin secretion and resistance Diabetes Care May 2003 26:1333-1337; doi:10.2337/diacare.26.5.1333

  6. Carter-Edwards, Lori

    • Lipid Testing Among Patients With Diabetes Who Receive Diabetes Care From Primary Care Physicians Diabetes Care May 2003 26:1369-1373; doi:10.2337/diacare.26.5.1369

  7. Caselli, Antonella

    • Contribution of Plantar Fascia to the Increased Forefoot Pressures in Diabetic Patients Diabetes Care May 2003 26:1525-1529; doi:10.2337/diacare.26.5.1525

  8. Cassader, Maurizio

    • Prevalence of Type 1 Diabetes-Related Autoantibodies in Adults With Celiac Disease Diabetes Care May 2003 26:1644-1645; doi:10.2337/diacare.26.5.1644

  9. Catapano, Alberico

    • Effects of an Automated Electronic Reminder in Changing the Antiplatelet Drug–Prescribing Behavior Among Italian General Practitioners in Diabetic Patients: An intervention trial Diabetes Care May 2003 26:1497-1500; doi:10.2337/diacare.26.5.1497

  10. Ceriello, Antonio

    • New Insights on Oxidative Stress and Diabetic Complications May Lead to a “Causal” Antioxidant Therapy Diabetes Care May 2003 26:1589-1596; doi:10.2337/diacare.26.5.1589

  11. Chan, Juliana C.N.

    • Renin-Angiotensin System Gene Polymorphisms and Retinopathy in Chinese Patients With Type 2 Diabetes Diabetes Care May 2003 26:1643-1644; doi:10.2337/diacare.26.5.1643

  12. Chase, H. Peter

    • Modem Transmission of Glucose Values Reduces the Costs and Need for Clinic Visits Diabetes Care May 2003 26:1475-1479; doi:10.2337/diacare.26.5.1475

  13. Cheong, Benjamin

    • Association of Hypoglycemia and Cardiac Ischemia: A study based on continuous monitoring Diabetes Care May 2003 26:1485-1489; doi:10.2337/diacare.26.5.1485

  14. Ciotola, Myriam

    • Cytokine Milieu Tends Toward Inflammation in Type 2 Diabetes Diabetes Care May 2003 26:1647; doi:10.2337/diacare.26.5.1647

  15. Clore, Jennifer

    • Fibrinogen Is a Marker for Nephropathy and Peripheral Vascular Disease in Type 1 Diabetes: Studies of plasma fibrinogen and fibrinogen gene polymorphism in the DCCT/EDIC cohort Diabetes Care May 2003 26:1439-1448; doi:10.2337/diacare.26.5.1439

  16. Cockram, Clive S.

    • Renin-Angiotensin System Gene Polymorphisms and Retinopathy in Chinese Patients With Type 2 Diabetes Diabetes Care May 2003 26:1643-1644; doi:10.2337/diacare.26.5.1643

  17. Cohen, Ohad

    • Effect of Acute Psychotic Stress in Nondiabetic Subjects on β-Cell Function and Insulin Sensitivity Diabetes Care May 2003 26:1462-1467; doi:10.2337/diacare.26.5.1462

  18. Collins, Dorothea

    • Insulin Resistance and Cardiovascular Events With Low HDL Cholesterol: The Veterans Affairs HDL Intervention Trial (VA-HIT) Diabetes Care May 2003 26:1513-1517; doi:10.2337/diacare.26.5.1513

  19. Conti, Elena

    • IGF-1 and Macrovascular Complications of Diabetes: Alternative interpretations of recently published data Diabetes Care May 2003 26:1653-1654; doi:10.2337/diacare.26.5.1653

  20. Corrado, Francesco

  21. Costa, Emanuela

    • Intensive Replacement of Basal Insulin in Patients With Type 1 Diabetes Given Rapid-Acting Insulin Analog at Mealtime: A 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime Diabetes Care May 2003 26:1490-1496; doi:10.2337/diacare.26.5.1490

  22. Couper, David

    • Detection of Undiagnosed Diabetes and Other Hyperglycemia States: The Atherosclerosis Risk in Communities Study Diabetes Care May 2003 26:1338-1343; doi:10.2337/diacare.26.5.1338

  23. Couper, Jennifer J.

    • Dietary Fats Do Not Contribute to Hyperlipidemia in Children and Adolescents With Type 1 Diabetes Diabetes Care May 2003 26:1356-1361; doi:10.2337/diacare.26.5.1356

  24. Crea, Filippo

    • IGF-1 and Macrovascular Complications of Diabetes: Alternative interpretations of recently published data Diabetes Care May 2003 26:1653-1654; doi:10.2337/diacare.26.5.1653

  25. Cricelli, Claudio

    • Effects of an Automated Electronic Reminder in Changing the Antiplatelet Drug–Prescribing Behavior Among Italian General Practitioners in Diabetic Patients: An intervention trial Diabetes Care May 2003 26:1497-1500; doi:10.2337/diacare.26.5.1497

  26. Critchley, Julian A.J.H.

    • Renin-Angiotensin System Gene Polymorphisms and Retinopathy in Chinese Patients With Type 2 Diabetes Diabetes Care May 2003 26:1643-1644; doi:10.2337/diacare.26.5.1643

D

  1. Dalton, R. Neil

    • Low IGF-I and Elevated Testosterone During Puberty in Subjects With Type 1 Diabetes Developing Microalbuminuria in Comparison to Normoalbuminuric Control Subjects: The Oxford Regional Prospective Study Diabetes Care May 2003 26:1456-1461; doi:10.2337/diacare.26.5.1456

  2. Damm, Peter

    • Audit on Stillbirths in Women With Pregestational Type 1 Diabetes Diabetes Care May 2003 26:1385-1389; doi:10.2337/diacare.26.5.1385

  3. Davidson, Mayer B.

  4. Davies, Nichola

    • Effect of 2-Week Treatment With Pirenzepine on Fasting and Postprandial Glucose Concentrations in Individuals With Type 2 Diabetes Diabetes Care May 2003 26:1636-1637; doi:10.2337/diacare.26.5.1636

  5. De Angelis, Massimiliano

  6. DeFronzo, Ralph A.

    • Analysis of Metabolic Parameters as Predictors of Risk in the RENAAL Study Diabetes Care May 2003 26:1402-1407; doi:10.2337/diacare.26.5.1402

  7. Deinum, Jaap

    • Long-Term Renoprotective Effects of Losartan in Diabetic Nephropathy: Interaction with ACE insertion/deletion genotype? Diabetes Care May 2003 26:1501-1506; doi:10.2337/diacare.26.5.1501

  8. Deira, Javier

    • Complete Blockade of the Renin-Angiotensin System in Patients With Advanced Diabetic Nephropathy Diabetes Care May 2003 26:1635-1636; doi:10.2337/diacare.26.5.1635-a

  9. Dekker, Jacqueline M.

    • Prospective Relation of C-Reactive Protein With Type 2 Diabetes: Response to Han et al. Diabetes Care May 2003 26:1656-1657; doi:10.2337/diacare.26.5.1656

  10. Dennis, Karen E.

    • Visceral Adipose Tissue Cutoffs Associated With Metabolic Risk Factors for Coronary Heart Disease in Women Diabetes Care May 2003 26:1413-1420; doi:10.2337/diacare.26.5.1413

  11. Derewlany, Lidia

    • Transfer of Insulin Lispro Across the Human Placenta: In vitro perfusion studies Diabetes Care May 2003 26:1390-1394; doi:10.2337/diacare.26.5.1390

  12. Desouza, Cyrus

    • Association of Hypoglycemia and Cardiac Ischemia: A study based on continuous monitoring Diabetes Care May 2003 26:1485-1489; doi:10.2337/diacare.26.5.1485

  13. Devita, Nicole G.

    • Polypharmacy and Medication Adherence in Patients With Type 2 Diabetes Diabetes Care May 2003 26:1408-1412; doi:10.2337/diacare.26.5.1408

  14. Di Palo, Carmen

    • Cytokine Milieu Tends Toward Inflammation in Type 2 Diabetes Diabetes Care May 2003 26:1647; doi:10.2337/diacare.26.5.1647

  15. Diaz, Hugo

    • Complete Blockade of the Renin-Angiotensin System in Patients With Advanced Diabetic Nephropathy Diabetes Care May 2003 26:1635-1636; doi:10.2337/diacare.26.5.1635-a

  16. Dickson, Tania Z.

    • Analysis of Metabolic Parameters as Predictors of Risk in the RENAAL Study Diabetes Care May 2003 26:1402-1407; doi:10.2337/diacare.26.5.1402

  17. Dietz, Kelly

    • Risk Factors for Diabetes in Familial Partial Lipodystrophy, Dunnigan Variety Diabetes Care May 2003 26:1350-1355; doi:10.2337/diacare.26.5.1350

  18. Duncan, Bruce B.

    • Detection of Undiagnosed Diabetes and Other Hyperglycemia States: The Atherosclerosis Risk in Communities Study Diabetes Care May 2003 26:1338-1343; doi:10.2337/diacare.26.5.1338

  19. Dunger, David B.

    • Low IGF-I and Elevated Testosterone During Puberty in Subjects With Type 1 Diabetes Developing Microalbuminuria in Comparison to Normoalbuminuric Control Subjects: The Oxford Regional Prospective Study Diabetes Care May 2003 26:1456-1461; doi:10.2337/diacare.26.5.1456

  20. Duvillard, Laurence

    • Cell Surface Expression of LDL Receptor Is Decreased in Type 2 Diabetic Patients and Is Normalized by Insulin Therapy Diabetes Care May 2003 26:1540-1544; doi:10.2337/diacare.26.5.1540

  21. D’Agostino, Maria Antonietta

    • Contribution of Plantar Fascia to the Increased Forefoot Pressures in Diabetic Patients Diabetes Care May 2003 26:1525-1529; doi:10.2337/diacare.26.5.1525

  22. D’Agostino, Ralph B.

    • Differences in LDL Oxidizability by Glycemic Status: The Insulin Resistance Atherosclerosis Study Diabetes Care May 2003 26:1449-1455; doi:10.2337/diacare.26.5.1449

  23. D’Ambrogi, Emanuela

    • Contribution of Plantar Fascia to the Increased Forefoot Pressures in Diabetic Patients Diabetes Care May 2003 26:1525-1529; doi:10.2337/diacare.26.5.1525

  24. de Pablos-Velasco, Pedro

    • The Relation Between Physical Activity and Metabolic Control in Type 2 Diabetes With <20 Years of Evolution Diabetes Care May 2003 26:1648-1650; doi:10.2337/diacare.26.5.1648

  25. den Heijer, Martin

    • Improved Insulin Sensitivity and Metabolic Control in Type 2 Diabetes Does Not Influence Plasma Homocysteine Diabetes Care May 2003 26:1637-1639; doi:10.2337/diacare.26.5.1637

E

  1. Edwards, Lynn

    • Stages of Change for Healthy Eating in Diabetes: Relation to demographic, eating-related, health care utilization, and psychosocial factors Diabetes Care May 2003 26:1468-1474; doi:10.2337/diacare.26.5.1468

  2. Ekbom, Pia

    • Audit on Stillbirths in Women With Pregestational Type 1 Diabetes Diabetes Care May 2003 26:1385-1389; doi:10.2337/diacare.26.5.1385

  3. Elam, Marshall B.

    • Insulin Resistance and Cardiovascular Events With Low HDL Cholesterol: The Veterans Affairs HDL Intervention Trial (VA-HIT) Diabetes Care May 2003 26:1513-1517; doi:10.2337/diacare.26.5.1513

  4. Elasy, Tom A.

    • Glycemic Relapse After an Intensive Outpatient Intervention for Type 2 Diabetes Diabetes Care May 2003 26:1645-1646; doi:10.2337/diacare.26.5.1645

  5. Eliasziw, Michael

  6. Ellis, Demetrius

    • Insulin Resistance–Related Factors, but not Glycemia, Predict Coronary Artery Disease in Type 1 Diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications study Diabetes Care May 2003 26:1374-1379; doi:10.2337/diacare.26.5.1374

  7. Emoto, Masanori

    • Factors Affecting Progression of Renal Failure in Patients With Type 2 Diabetes Diabetes Care May 2003 26:1530-1534; doi:10.2337/diacare.26.5.1530

  8. Erbey, John R.

    • Insulin Resistance–Related Factors, but not Glycemia, Predict Coronary Artery Disease in Type 1 Diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications study Diabetes Care May 2003 26:1374-1379; doi:10.2337/diacare.26.5.1374

  9. Escobar-Jimenez, Fernando

    • Analysis of Metabolic Parameters as Predictors of Risk in the RENAAL Study Diabetes Care May 2003 26:1402-1407; doi:10.2337/diacare.26.5.1402

  10. Esposito, Katherine

    • Cytokine Milieu Tends Toward Inflammation in Type 2 Diabetes Diabetes Care May 2003 26:1647; doi:10.2337/diacare.26.5.1647
    • Stress Hyperglycemia, Inflammation, and Cardiovascular Events Diabetes Care May 2003 26:1650-1651; doi:10.2337/diacare.26.5.1650-a

F

  1. Faas, Fred H.

    • Insulin Resistance and Cardiovascular Events With Low HDL Cholesterol: The Veterans Affairs HDL Intervention Trial (VA-HIT) Diabetes Care May 2003 26:1513-1517; doi:10.2337/diacare.26.5.1513

  2. Facciolà, Graziella

  3. Faichney, J. David

    • Metformin in Type 1 Diabetes: Is this a good or bad idea? Diabetes Care May 2003 26:1655; doi:10.2337/diacare.26.5.1655

  4. Fanelli, Carmine

    • Intensive Replacement of Basal Insulin in Patients With Type 1 Diabetes Given Rapid-Acting Insulin Analog at Mealtime: A 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime Diabetes Care May 2003 26:1490-1496; doi:10.2337/diacare.26.5.1490

  5. Fauvel, Josette

    • Differential Levels of γ-Glutamyl Transferase Activity and Apolipoprotein CIII in Men on Either Statin or Fibrate Therapy Diabetes Care May 2003 26:1652-1653; doi:10.2337/diacare.26.5.1652

  6. Feig, Denice S.

    • Transfer of Insulin Lispro Across the Human Placenta: In vitro perfusion studies Diabetes Care May 2003 26:1390-1394; doi:10.2337/diacare.26.5.1390

  7. Fernández-Real, José-Manuel

    • Insulin Resistance, Inflammation, and Serum Fatty Acid Composition Diabetes Care May 2003 26:1362-1368; doi:10.2337/diacare.26.5.1362

  8. Ferrières, Jean

    • Differential Levels of γ-Glutamyl Transferase Activity and Apolipoprotein CIII in Men on Either Statin or Fibrate Therapy Diabetes Care May 2003 26:1652-1653; doi:10.2337/diacare.26.5.1652

  9. Filippi, Alessandro

    • Effects of an Automated Electronic Reminder in Changing the Antiplatelet Drug–Prescribing Behavior Among Italian General Practitioners in Diabetic Patients: An intervention trial Diabetes Care May 2003 26:1497-1500; doi:10.2337/diacare.26.5.1497

  10. Fitzgerald, James T.

    • The Diabetes Empowerment Scale-Short Form (DES-SF) Diabetes Care May 2003 26:1641-1642; doi:10.2337/diacare.26.5.1641-a

  11. Florentin, Emmanuel

    • Cell Surface Expression of LDL Receptor Is Decreased in Type 2 Diabetic Patients and Is Normalized by Insulin Therapy Diabetes Care May 2003 26:1540-1544; doi:10.2337/diacare.26.5.1540

  12. Folsom, Aaron R.

    • Detection of Undiagnosed Diabetes and Other Hyperglycemia States: The Atherosclerosis Risk in Communities Study Diabetes Care May 2003 26:1338-1343; doi:10.2337/diacare.26.5.1338

  13. Fonseca, Vivian

    • Association of Hypoglycemia and Cardiac Ischemia: A study based on continuous monitoring Diabetes Care May 2003 26:1485-1489; doi:10.2337/diacare.26.5.1485

  14. Forrest, Kimberly Y.-Z.

    • Insulin Resistance–Related Factors, but not Glycemia, Predict Coronary Artery Disease in Type 1 Diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications study Diabetes Care May 2003 26:1374-1379; doi:10.2337/diacare.26.5.1374

  15. Franco, Aurora

    • Analysis of the Agreement Between the World Health Organization Criteria and the National Cholesterol Education Program-III Definition of the Metabolic Syndrome: Results from a population-based survey Diabetes Care May 2003 26:1635; doi:10.2337/diacare.26.5.1635

  16. Freeman, Roy

  17. Friedman, Bernard

  18. Frystyk, Jan

    • Low IGF-I and Elevated Testosterone During Puberty in Subjects With Type 1 Diabetes Developing Microalbuminuria in Comparison to Normoalbuminuric Control Subjects: The Oxford Regional Prospective Study Diabetes Care May 2003 26:1456-1461; doi:10.2337/diacare.26.5.1456

  19. Fukumoto, Shinya

    • Factors Affecting Progression of Renal Failure in Patients With Type 2 Diabetes Diabetes Care May 2003 26:1530-1534; doi:10.2337/diacare.26.5.1530

  20. Funnell, Martha M.

    • The Diabetes Empowerment Scale-Short Form (DES-SF) Diabetes Care May 2003 26:1641-1642; doi:10.2337/diacare.26.5.1641-a

G

  1. Gabazza, Esteban C.

    • Increased Oxidative Stress Is Associated With Elevated Plasma Levels of Adrenomedullin in Hypertensive Patients With Type 2 Diabetes Diabetes Care May 2003 26:1642-1643; doi:10.2337/diacare.26.5.1642

  2. Galland, Françoise

    • Cell Surface Expression of LDL Receptor Is Decreased in Type 2 Diabetic Patients and Is Normalized by Insulin Therapy Diabetes Care May 2003 26:1540-1544; doi:10.2337/diacare.26.5.1540

  3. Gambert, Philippe

    • Cell Surface Expression of LDL Receptor Is Decreased in Type 2 Diabetic Patients and Is Normalized by Insulin Therapy Diabetes Care May 2003 26:1540-1544; doi:10.2337/diacare.26.5.1540

  4. Garg, Abhimanyu

    • Risk Factors for Diabetes in Familial Partial Lipodystrophy, Dunnigan Variety Diabetes Care May 2003 26:1350-1355; doi:10.2337/diacare.26.5.1350

  5. Garg, Satish K.

    • Modem Transmission of Glucose Values Reduces the Costs and Need for Clinic Visits Diabetes Care May 2003 26:1475-1479; doi:10.2337/diacare.26.5.1475

  6. Garvey, W. Timothy

    • Fibrinogen Is a Marker for Nephropathy and Peripheral Vascular Disease in Type 1 Diabetes: Studies of plasma fibrinogen and fibrinogen gene polymorphism in the DCCT/EDIC cohort Diabetes Care May 2003 26:1439-1448; doi:10.2337/diacare.26.5.1439

  7. Ghirlanda, Giovanni

    • IGF-1 and Macrovascular Complications of Diabetes: Alternative interpretations of recently published data Diabetes Care May 2003 26:1653-1654; doi:10.2337/diacare.26.5.1653

  8. Giacomozzi, Claudia

    • Contribution of Plantar Fascia to the Increased Forefoot Pressures in Diabetic Patients Diabetes Care May 2003 26:1525-1529; doi:10.2337/diacare.26.5.1525

  9. Giugliano, Dario

    • Cytokine Milieu Tends Toward Inflammation in Type 2 Diabetes Diabetes Care May 2003 26:1647; doi:10.2337/diacare.26.5.1647
    • Stress Hyperglycemia, Inflammation, and Cardiovascular Events Diabetes Care May 2003 26:1650-1651; doi:10.2337/diacare.26.5.1650-a

  10. Giugliano, Francesco

    • Cytokine Milieu Tends Toward Inflammation in Type 2 Diabetes Diabetes Care May 2003 26:1647; doi:10.2337/diacare.26.5.1647

  11. Giurato, Laura

    • Contribution of Plantar Fascia to the Increased Forefoot Pressures in Diabetic Patients Diabetes Care May 2003 26:1525-1529; doi:10.2337/diacare.26.5.1525

  12. Goff, David. C.

    • Differences in LDL Oxidizability by Glycemic Status: The Insulin Resistance Atherosclerosis Study Diabetes Care May 2003 26:1449-1455; doi:10.2337/diacare.26.5.1449

  13. Gonzalez-Villalpando, Clicerio

    • Prospective Relation of C-Reactive Protein With Type 2 Diabetes: Response to Snijder et al. Diabetes Care May 2003 26:1657-1658; doi:10.2337/diacare.26.5.1657

  14. Graber, Alan L.

    • Glycemic Relapse After an Intensive Outpatient Intervention for Type 2 Diabetes Diabetes Care May 2003 26:1645-1646; doi:10.2337/diacare.26.5.1645

  15. Grande, Jesús

    • Complete Blockade of the Renin-Angiotensin System in Patients With Advanced Diabetic Nephropathy Diabetes Care May 2003 26:1635-1636; doi:10.2337/diacare.26.5.1635-a

  16. Grant, Richard W.

    • Polypharmacy and Medication Adherence in Patients With Type 2 Diabetes Diabetes Care May 2003 26:1408-1412; doi:10.2337/diacare.26.5.1408

  17. Greene, Geoffrey

    • Stages of Change for Healthy Eating in Diabetes: Relation to demographic, eating-related, health care utilization, and psychosocial factors Diabetes Care May 2003 26:1468-1474; doi:10.2337/diacare.26.5.1468

  18. Groop, Leif

    • Importance of Obtaining Independent Measures of Insulin Secretion and Insulin Sensitivity During the Same Test: Results with the Botnia clamp Diabetes Care May 2003 26:1395-1401; doi:10.2337/diacare.26.5.1395

  19. Gruppen, Larry D.

    • The Diabetes Empowerment Scale-Short Form (DES-SF) Diabetes Care May 2003 26:1641-1642; doi:10.2337/diacare.26.5.1641-a

  20. Guerci, Bruno

    • Metformin and Insulin in Type 1 Diabetes: The first step Diabetes Care May 2003 26:1655-1656; doi:10.2337/diacare.26.5.1655-a

  21. Guidetti, Carla Sategna

    • Prevalence of Type 1 Diabetes-Related Autoantibodies in Adults With Celiac Disease Diabetes Care May 2003 26:1644-1645; doi:10.2337/diacare.26.5.1644

  22. Gullström, Monica

    • Importance of Obtaining Independent Measures of Insulin Secretion and Insulin Sensitivity During the Same Test: Results with the Botnia clamp Diabetes Care May 2003 26:1395-1401; doi:10.2337/diacare.26.5.1395

  23. Gómez-Pérez, Francisco J.

    • Analysis of the Agreement Between the World Health Organization Criteria and the National Cholesterol Education Program-III Definition of the Metabolic Syndrome: Results from a population-based survey Diabetes Care May 2003 26:1635; doi:10.2337/diacare.26.5.1635

H

  1. Haffner, Steven M.

    • Prospective Relation of C-Reactive Protein With Type 2 Diabetes: Response to Snijder et al. Diabetes Care May 2003 26:1657-1658; doi:10.2337/diacare.26.5.1657

  2. Han, Thang S.

    • Prospective Relation of C-Reactive Protein With Type 2 Diabetes: Response to Snijder et al. Diabetes Care May 2003 26:1657-1658; doi:10.2337/diacare.26.5.1657

  3. Haque, Wasim A.

    • Risk Factors for Diabetes in Familial Partial Lipodystrophy, Dunnigan Variety Diabetes Care May 2003 26:1350-1355; doi:10.2337/diacare.26.5.1350

  4. Harkless, Lawrence B.

    • Dermatophyte Test Medium Culture for Evaluating Toenail Infections in Patients With Diabetes Diabetes Care May 2003 26:1480-1484; doi:10.2337/diacare.26.5.1480

  5. Hayashi, Keiko

    • Laughter Lowered the Increase in Postprandial Blood Glucose Diabetes Care May 2003 26:1651-1652; doi:10.2337/diacare.26.5.1651

  6. Hayashi, Takashi

    • Laughter Lowered the Increase in Postprandial Blood Glucose Diabetes Care May 2003 26:1651-1652; doi:10.2337/diacare.26.5.1651

  7. Hegele, Robert A.

  8. Heine, Robert J.

    • Prospective Relation of C-Reactive Protein With Type 2 Diabetes: Response to Han et al. Diabetes Care May 2003 26:1656-1657; doi:10.2337/diacare.26.5.1656

  9. Henley, Nancy S.

    • Lipid Testing Among Patients With Diabetes Who Receive Diabetes Care From Primary Care Physicians Diabetes Care May 2003 26:1369-1373; doi:10.2337/diacare.26.5.1369

  10. Herman, William H.

    • A Multivariate Logistic Regression Equation to Screen for Diabetes: Response to Roze, Palmer, and Valentine Diabetes Care May 2003 26:1659; doi:10.2337/diacare.26.5.1659

  11. Hermus, Ad R.

    • Improved Insulin Sensitivity and Metabolic Control in Type 2 Diabetes Does Not Influence Plasma Homocysteine Diabetes Care May 2003 26:1637-1639; doi:10.2337/diacare.26.5.1637

  12. Hille, Darcy A.

    • Analysis of Metabolic Parameters as Predictors of Risk in the RENAAL Study Diabetes Care May 2003 26:1402-1407; doi:10.2337/diacare.26.5.1402

  13. Hirano, Ken-ichi

    • Lipoprotein Abnormalities in Human Genetic CD36 Deficiency Associated With Insulin Resistance and Abnormal Fatty Acid Metabolism Diabetes Care May 2003 26:1647-1648; doi:10.2337/diacare.26.5.1647-a

  14. Hiraoka, Hisatoyo

    • Lipoprotein Abnormalities in Human Genetic CD36 Deficiency Associated With Insulin Resistance and Abnormal Fatty Acid Metabolism Diabetes Care May 2003 26:1647-1648; doi:10.2337/diacare.26.5.1647-a

  15. Hirsch, Irl B.

  16. Hirte, Craig

    • Dietary Fats Do Not Contribute to Hyperlipidemia in Children and Adolescents With Type 1 Diabetes Diabetes Care May 2003 26:1356-1361; doi:10.2337/diacare.26.5.1356

  17. Hogan, Paul F.

    • A Model to Determine Workforce Needs for Endocrinologists in the United States Until 2020 Diabetes Care May 2003 26:1545-1552; doi:10.2337/diacare.26.5.1545

  18. Hood, Kerenza

    • Effect of 2-Week Treatment With Pirenzepine on Fasting and Postprandial Glucose Concentrations in Individuals With Type 2 Diabetes Diabetes Care May 2003 26:1636-1637; doi:10.2337/diacare.26.5.1636

  19. Hori, Yasuko

    • Increased Oxidative Stress Is Associated With Elevated Plasma Levels of Adrenomedullin in Hypertensive Patients With Type 2 Diabetes Diabetes Care May 2003 26:1642-1643; doi:10.2337/diacare.26.5.1642

  20. Hunter, Steven J.

    • Fibrinogen Is a Marker for Nephropathy and Peripheral Vascular Disease in Type 1 Diabetes: Studies of plasma fibrinogen and fibrinogen gene polymorphism in the DCCT/EDIC cohort Diabetes Care May 2003 26:1439-1448; doi:10.2337/diacare.26.5.1439

  21. Hux, Janet E.

    • Processes and Outcomes of Care for Diabetic Acute Myocardial Infarction Patients in Ontario: Do physicians undertreat? Diabetes Care May 2003 26:1427-1434; doi:10.2337/diacare.26.5.1427

I

  1. Inaba, Masaaki

    • Factors Affecting Progression of Renal Failure in Patients With Type 2 Diabetes Diabetes Care May 2003 26:1530-1534; doi:10.2337/diacare.26.5.1530

  2. Ishibashi, Shun

    • HLA-DR-DQ Haplotype in Rapid-Onset Type 1 Diabetes in Japanese Diabetes Care May 2003 26:1640-1641; doi:10.2337/diacare.26.5.1640

  3. Ishigami, Masato

    • Lipoprotein Abnormalities in Human Genetic CD36 Deficiency Associated With Insulin Resistance and Abnormal Fatty Acid Metabolism Diabetes Care May 2003 26:1647-1648; doi:10.2337/diacare.26.5.1647-a

  4. Ishii, Hitoshi

    • Laughter Lowered the Increase in Postprandial Blood Glucose Diabetes Care May 2003 26:1651-1652; doi:10.2337/diacare.26.5.1651

  5. Ishimura, Eiji

    • Factors Affecting Progression of Renal Failure in Patients With Type 2 Diabetes Diabetes Care May 2003 26:1530-1534; doi:10.2337/diacare.26.5.1530

  6. Issa, Basil G.

    • Effect of 2-Week Treatment With Pirenzepine on Fasting and Postprandial Glucose Concentrations in Individuals With Type 2 Diabetes Diabetes Care May 2003 26:1636-1637; doi:10.2337/diacare.26.5.1636

  7. Iwanaga, Shizuko

    • Laughter Lowered the Increase in Postprandial Blood Glucose Diabetes Care May 2003 26:1651-1652; doi:10.2337/diacare.26.5.1651

J

  1. Janko, Otmar

    • The True Overall Mortality of Unselected Nephropathic Type 2 Diabetic Patients With Mild to Moderate Renal Insufficiency Diabetes Care May 2003 26:1639-1640; doi:10.2337/diacare.26.5.1639

  2. Jenkins, Alicia J.

    • Fibrinogen Is a Marker for Nephropathy and Peripheral Vascular Disease in Type 1 Diabetes: Studies of plasma fibrinogen and fibrinogen gene polymorphism in the DCCT/EDIC cohort Diabetes Care May 2003 26:1439-1448; doi:10.2337/diacare.26.5.1439

  3. Jiang, H. Joanna

  4. Jones, Helen

    • Stages of Change for Healthy Eating in Diabetes: Relation to demographic, eating-related, health care utilization, and psychosocial factors Diabetes Care May 2003 26:1468-1474; doi:10.2337/diacare.26.5.1468

  5. Juhl, Tina R.

    • Long-Term Renoprotective Effects of Losartan in Diabetic Nephropathy: Interaction with ACE insertion/deletion genotype? Diabetes Care May 2003 26:1501-1506; doi:10.2337/diacare.26.5.1501

K

  1. Kahn, Richard

    • A Model to Determine Workforce Needs for Endocrinologists in the United States Until 2020 Diabetes Care May 2003 26:1545-1552; doi:10.2337/diacare.26.5.1545

  2. Karter, Andrew J.

    • Differences in LDL Oxidizability by Glycemic Status: The Insulin Resistance Atherosclerosis Study Diabetes Care May 2003 26:1449-1455; doi:10.2337/diacare.26.5.1449

  3. Katsuki, Akira

    • Increased Oxidative Stress Is Associated With Elevated Plasma Levels of Adrenomedullin in Hypertensive Patients With Type 2 Diabetes Diabetes Care May 2003 26:1642-1643; doi:10.2337/diacare.26.5.1642

  4. Kawai, Koichi

    • Laughter Lowered the Increase in Postprandial Blood Glucose Diabetes Care May 2003 26:1651-1652; doi:10.2337/diacare.26.5.1651

  5. Khaykin, Yaariv

    • Processes and Outcomes of Care for Diabetic Acute Myocardial Infarction Patients in Ontario: Do physicians undertreat? Diabetes Care May 2003 26:1427-1434; doi:10.2337/diacare.26.5.1427

  6. King, Dana E.

    • C-Reactive Protein and Glycemic Control in Adults With Diabetes Diabetes Care May 2003 26:1535-1539; doi:10.2337/diacare.26.5.1535

  7. Kiritoshi, Shinsuke

    • Evaluation of Urinary 8-Hydroxydeoxy-Guanosine as a Novel Biomarker of Macrovascular Complications in Type 2 Diabetes Diabetes Care May 2003 26:1507-1512; doi:10.2337/diacare.26.5.1507

  8. Kishikawa, Hideki

    • Evaluation of Urinary 8-Hydroxydeoxy-Guanosine as a Novel Biomarker of Macrovascular Complications in Type 2 Diabetes Diabetes Care May 2003 26:1507-1512; doi:10.2337/diacare.26.5.1507

  9. Kitagawa, Nagako

    • Increased Oxidative Stress Is Associated With Elevated Plasma Levels of Adrenomedullin in Hypertensive Patients With Type 2 Diabetes Diabetes Care May 2003 26:1642-1643; doi:10.2337/diacare.26.5.1642

  10. Klein, Richard L.

    • Fibrinogen Is a Marker for Nephropathy and Peripheral Vascular Disease in Type 1 Diabetes: Studies of plasma fibrinogen and fibrinogen gene polymorphism in the DCCT/EDIC cohort Diabetes Care May 2003 26:1439-1448; doi:10.2337/diacare.26.5.1439

  11. Klonoff, David C.

    • Diabetes and Telemedicine: Is the technology sound, effective, cost-effective, and practical? Diabetes Care May 2003 26:1626-1628; doi:10.2337/diacare.26.5.1626

  12. Knie, Brenda

    • Transfer of Insulin Lispro Across the Human Placenta: In vitro perfusion studies Diabetes Care May 2003 26:1390-1394; doi:10.2337/diacare.26.5.1390

  13. Koren, Gideon

    • Transfer of Insulin Lispro Across the Human Placenta: In vitro perfusion studies Diabetes Care May 2003 26:1390-1394; doi:10.2337/diacare.26.5.1390

  14. Kukidome, Daisuke

    • Evaluation of Urinary 8-Hydroxydeoxy-Guanosine as a Novel Biomarker of Macrovascular Complications in Type 2 Diabetes Diabetes Care May 2003 26:1507-1512; doi:10.2337/diacare.26.5.1507

  15. Kusaka, Ikuyo

    • HLA-DR-DQ Haplotype in Rapid-Onset Type 1 Diabetes in Japanese Diabetes Care May 2003 26:1640-1641; doi:10.2337/diacare.26.5.1640

  16. Kuwasako, Takahiro

    • Lipoprotein Abnormalities in Human Genetic CD36 Deficiency Associated With Insulin Resistance and Abnormal Fatty Acid Metabolism Diabetes Care May 2003 26:1647-1648; doi:10.2337/diacare.26.5.1647-a

L

  1. Ladenson, Paul W.

    • A Model to Determine Workforce Needs for Endocrinologists in the United States Until 2020 Diabetes Care May 2003 26:1545-1552; doi:10.2337/diacare.26.5.1545

  2. Lam, Dennis

    • Renin-Angiotensin System Gene Polymorphisms and Retinopathy in Chinese Patients With Type 2 Diabetes Diabetes Care May 2003 26:1643-1644; doi:10.2337/diacare.26.5.1643

  3. Lauenborg, Jeannet

    • Audit on Stillbirths in Women With Pregestational Type 1 Diabetes Diabetes Care May 2003 26:1385-1389; doi:10.2337/diacare.26.5.1385

  4. Lavery, Lawrence A.

    • Diabetic Foot Syndrome: Evaluating the prevalence and incidence of foot pathology in Mexican Americans and non-Hispanic whites from a diabetes disease management cohort Diabetes Care May 2003 26:1435-1438; doi:10.2337/diacare.26.5.1435

  5. Lean, Michael E.J.

    • Patients on Atypical Antipsychotic Drugs: Another high-risk group for type 2 diabetes Diabetes Care May 2003 26:1597-1605; doi:10.2337/diacare.26.5.1597
    • Prospective Relation of C-Reactive Protein With Type 2 Diabetes: Response to Snijder et al. Diabetes Care May 2003 26:1657-1658; doi:10.2337/diacare.26.5.1657

  6. Leinonen, Eeva S.

    • IGF Binding Protein-1 and Carotid Intima-Media Thickness in Type 2 Diabetes: Response to Conti et al. Diabetes Care May 2003 26:1654-1655; doi:10.2337/diacare.26.5.1654

  7. Leinonen, Pekka J.

    • IGF Binding Protein-1 and Carotid Intima-Media Thickness in Type 2 Diabetes: Response to Conti et al. Diabetes Care May 2003 26:1654-1655; doi:10.2337/diacare.26.5.1654

  8. Lenhard, M. James

  9. Lizard, Gérard

    • Cell Surface Expression of LDL Receptor Is Decreased in Type 2 Diabetic Patients and Is Normalized by Insulin Therapy Diabetes Care May 2003 26:1540-1544; doi:10.2337/diacare.26.5.1540

  10. Lynch, Nicole A.

    • Visceral Adipose Tissue Cutoffs Associated With Metabolic Risk Factors for Coronary Heart Disease in Women Diabetes Care May 2003 26:1413-1420; doi:10.2337/diacare.26.5.1413

M

  1. Mabile, Laurence

    • Differential Levels of γ-Glutamyl Transferase Activity and Apolipoprotein CIII in Men on Either Statin or Fibrate Therapy Diabetes Care May 2003 26:1652-1653; doi:10.2337/diacare.26.5.1652

  2. Macellari, Velio

    • Contribution of Plantar Fascia to the Increased Forefoot Pressures in Diabetic Patients Diabetes Care May 2003 26:1525-1529; doi:10.2337/diacare.26.5.1525

  3. Maduli, Elisabetta

    • The Significance of Impaired Fasting Glucose Versus Impaired Glucose Tolerance: Importance of insulin secretion and resistance Diabetes Care May 2003 26:1333-1337; doi:10.2337/diacare.26.5.1333

  4. Mainous, Arch G.

    • C-Reactive Protein and Glycemic Control in Adults With Diabetes Diabetes Care May 2003 26:1535-1539; doi:10.2337/diacare.26.5.1535

  5. Man, Jeremy

    • Diabetes and Coronary Artery Bypass Surgery: An examination of perioperative glycemic control and outcomes Diabetes Care May 2003 26:1518-1524; doi:10.2337/diacare.26.5.1518

  6. Mancuso, Alfredo

  7. Marfella, Raffaele

    • Stress Hyperglycemia, Inflammation, and Cardiovascular Events Diabetes Care May 2003 26:1650-1651; doi:10.2337/diacare.26.5.1650-a

  8. Marrugat, Jaume

    • The Relation Between Physical Activity and Metabolic Control in Type 2 Diabetes With <20 Years of Evolution Diabetes Care May 2003 26:1648-1650; doi:10.2337/diacare.26.5.1648

  9. Martini, Silvia

    • Prevalence of Type 1 Diabetes-Related Autoantibodies in Adults With Celiac Disease Diabetes Care May 2003 26:1644-1645; doi:10.2337/diacare.26.5.1644

  10. Maruyama, Noriko

    • Increased Oxidative Stress Is Associated With Elevated Plasma Levels of Adrenomedullin in Hypertensive Patients With Type 2 Diabetes Diabetes Care May 2003 26:1642-1643; doi:10.2337/diacare.26.5.1642

  11. Maser, Raelene E.

  12. Massing, Mark W.

    • Lipid Testing Among Patients With Diabetes Who Receive Diabetes Care From Primary Care Physicians Diabetes Care May 2003 26:1369-1373; doi:10.2337/diacare.26.5.1369

  13. Mathiesen, Elisabeth

    • Audit on Stillbirths in Women With Pregestational Type 1 Diabetes Diabetes Care May 2003 26:1385-1389; doi:10.2337/diacare.26.5.1385

  14. Matsumoto, Naoki

    • Factors Affecting Progression of Renal Failure in Patients With Type 2 Diabetes Diabetes Care May 2003 26:1530-1534; doi:10.2337/diacare.26.5.1530

  15. Matsumura, Takeshi

    • Evaluation of Urinary 8-Hydroxydeoxy-Guanosine as a Novel Biomarker of Macrovascular Complications in Type 2 Diabetes Diabetes Care May 2003 26:1507-1512; doi:10.2337/diacare.26.5.1507

  16. Matsuo, Tomoko

    • Evaluation of Urinary 8-Hydroxydeoxy-Guanosine as a Novel Biomarker of Macrovascular Complications in Type 2 Diabetes Diabetes Care May 2003 26:1507-1512; doi:10.2337/diacare.26.5.1507

  17. Matsuzawa, Yuji

    • Lipoprotein Abnormalities in Human Genetic CD36 Deficiency Associated With Insulin Resistance and Abnormal Fatty Acid Metabolism Diabetes Care May 2003 26:1647-1648; doi:10.2337/diacare.26.5.1647-a

  18. Mazzaglia, Giampiero

    • Effects of an Automated Electronic Reminder in Changing the Antiplatelet Drug–Prescribing Behavior Among Italian General Practitioners in Diabetic Patients: An intervention trial Diabetes Care May 2003 26:1497-1500; doi:10.2337/diacare.26.5.1497

  19. McAlister, Finlay A.

    • Diabetes and Coronary Artery Bypass Surgery: An examination of perioperative glycemic control and outcomes Diabetes Care May 2003 26:1518-1524; doi:10.2337/diacare.26.5.1518

  20. Meigs, James B.

    • Polypharmacy and Medication Adherence in Patients With Type 2 Diabetes Diabetes Care May 2003 26:1408-1412; doi:10.2337/diacare.26.5.1408

  21. Meyer, Laurent

    • Metformin and Insulin in Type 1 Diabetes: The first step Diabetes Care May 2003 26:1655-1656; doi:10.2337/diacare.26.5.1655-a

  22. Miki, Takami

    • Factors Affecting Progression of Renal Failure in Patients With Type 2 Diabetes Diabetes Care May 2003 26:1530-1534; doi:10.2337/diacare.26.5.1530

  23. Mitchell, Braxton D.

  24. Miyamura, Nobuhiro

    • Evaluation of Urinary 8-Hydroxydeoxy-Guanosine as a Novel Biomarker of Macrovascular Complications in Type 2 Diabetes Diabetes Care May 2003 26:1507-1512; doi:10.2337/diacare.26.5.1507

  25. Mogensen, Carl Erik

    • Genetics and Diabetic Renal Disease: Still a big black hole Diabetes Care May 2003 26:1631-1632; doi:10.2337/diacare.26.5.1631

  26. Monereo, Susana

    • The Relation Between Physical Activity and Metabolic Control in Type 2 Diabetes With <20 Years of Evolution Diabetes Care May 2003 26:1648-1650; doi:10.2337/diacare.26.5.1648

  27. Monier, Serge

    • Cell Surface Expression of LDL Receptor Is Decreased in Type 2 Diabetic Patients and Is Normalized by Insulin Therapy Diabetes Care May 2003 26:1540-1544; doi:10.2337/diacare.26.5.1540

  28. Moreno, Basilio

    • The Relation Between Physical Activity and Metabolic Control in Type 2 Diabetes With <20 Years of Evolution Diabetes Care May 2003 26:1648-1650; doi:10.2337/diacare.26.5.1648

  29. Morioka, Kohei

    • Increased Oxidative Stress Is Associated With Elevated Plasma Levels of Adrenomedullin in Hypertensive Patients With Type 2 Diabetes Diabetes Care May 2003 26:1642-1643; doi:10.2337/diacare.26.5.1642

  30. Morioka, Tomoaki

    • Factors Affecting Progression of Renal Failure in Patients With Type 2 Diabetes Diabetes Care May 2003 26:1530-1534; doi:10.2337/diacare.26.5.1530

  31. Murakami, Kazuo

    • Laughter Lowered the Increase in Postprandial Blood Glucose Diabetes Care May 2003 26:1651-1652; doi:10.2337/diacare.26.5.1651

  32. Murgo, Joseph

    • Association of Hypoglycemia and Cardiac Ischemia: A study based on continuous monitoring Diabetes Care May 2003 26:1485-1489; doi:10.2337/diacare.26.5.1485

  33. Mølsted-Pedersen, Lars

    • Audit on Stillbirths in Women With Pregestational Type 1 Diabetes Diabetes Care May 2003 26:1385-1389; doi:10.2337/diacare.26.5.1385

N

  1. Nagasaka, Shoichiro

    • HLA-DR-DQ Haplotype in Rapid-Onset Type 1 Diabetes in Japanese Diabetes Care May 2003 26:1640-1641; doi:10.2337/diacare.26.5.1640

  2. Nakamura, Tomoatsu

    • HLA-DR-DQ Haplotype in Rapid-Onset Type 1 Diabetes in Japanese Diabetes Care May 2003 26:1640-1641; doi:10.2337/diacare.26.5.1640

  3. Nakatani, Kaname

    • Increased Oxidative Stress Is Associated With Elevated Plasma Levels of Adrenomedullin in Hypertensive Patients With Type 2 Diabetes Diabetes Care May 2003 26:1642-1643; doi:10.2337/diacare.26.5.1642

  4. Nappo, Francesco

    • Cytokine Milieu Tends Toward Inflammation in Type 2 Diabetes Diabetes Care May 2003 26:1647; doi:10.2337/diacare.26.5.1647

  5. Nicklas, Barbara J.

    • Visceral Adipose Tissue Cutoffs Associated With Metabolic Risk Factors for Coronary Heart Disease in Women Diabetes Care May 2003 26:1413-1420; doi:10.2337/diacare.26.5.1413

  6. Niefeld, Marlene R.

  7. Nijpels, Giel

    • Prospective Relation of C-Reactive Protein With Type 2 Diabetes: Response to Han et al. Diabetes Care May 2003 26:1656-1657; doi:10.2337/diacare.26.5.1656

  8. Nishikawa, Takeshi

    • Evaluation of Urinary 8-Hydroxydeoxy-Guanosine as a Novel Biomarker of Macrovascular Complications in Type 2 Diabetes Diabetes Care May 2003 26:1507-1512; doi:10.2337/diacare.26.5.1507

  9. Nishizawa, Yoshiki

    • Factors Affecting Progression of Renal Failure in Patients With Type 2 Diabetes Diabetes Care May 2003 26:1530-1534; doi:10.2337/diacare.26.5.1530

O

  1. Oderberg, Adam D.

    • Modem Transmission of Glucose Values Reduces the Costs and Need for Clinic Visits Diabetes Care May 2003 26:1475-1479; doi:10.2337/diacare.26.5.1475

  2. Oh, Mary S.

    • The Diabetes Empowerment Scale-Short Form (DES-SF) Diabetes Care May 2003 26:1641-1642; doi:10.2337/diacare.26.5.1641-a

  3. Olaiz, Gustavo

    • Analysis of the Agreement Between the World Health Organization Criteria and the National Cholesterol Education Program-III Definition of the Metabolic Syndrome: Results from a population-based survey Diabetes Care May 2003 26:1635; doi:10.2337/diacare.26.5.1635

  4. Olson, Jon C.

    • Insulin Resistance–Related Factors, but not Glycemia, Predict Coronary Artery Disease in Type 1 Diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications study Diabetes Care May 2003 26:1374-1379; doi:10.2337/diacare.26.5.1374

  5. Ong, Ken

    • Low IGF-I and Elevated Testosterone During Puberty in Subjects With Type 1 Diabetes Developing Microalbuminuria in Comparison to Normoalbuminuric Control Subjects: The Oxford Regional Prospective Study Diabetes Care May 2003 26:1456-1461; doi:10.2337/diacare.26.5.1456

  6. Oral, Elif Arioglu

    • Risk Factors for Diabetes in Familial Partial Lipodystrophy, Dunnigan Variety Diabetes Care May 2003 26:1350-1355; doi:10.2337/diacare.26.5.1350

  7. Orchard, Trevor J.

    • Insulin Resistance–Related Factors, but not Glycemia, Predict Coronary Artery Disease in Type 1 Diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications study Diabetes Care May 2003 26:1374-1379; doi:10.2337/diacare.26.5.1374

  8. Ovesen, Per

    • Audit on Stillbirths in Women With Pregestational Type 1 Diabetes Diabetes Care May 2003 26:1385-1389; doi:10.2337/diacare.26.5.1385

P

  1. Pagano, Gianfranco

    • Prevalence of Type 1 Diabetes-Related Autoantibodies in Adults With Celiac Disease Diabetes Care May 2003 26:1644-1645; doi:10.2337/diacare.26.5.1644

  2. Pajonk, Frank-Gerald

    • Patients on Atypical Antipsychotic Drugs: Another high-risk group for type 2 diabetes Diabetes Care May 2003 26:1597-1605; doi:10.2337/diacare.26.5.1597

  3. Palmer, Andrew J.

    • A Multivariate Logistic Regression Equation to Screen for Diabetes: Response to Tabaei and Herman Diabetes Care May 2003 26:1658-1659; doi:10.2337/diacare.26.5.1658

  4. Pampanelli, Simone

    • Intensive Replacement of Basal Insulin in Patients With Type 1 Diabetes Given Rapid-Acting Insulin Analog at Mealtime: A 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime Diabetes Care May 2003 26:1490-1496; doi:10.2337/diacare.26.5.1490

  5. Pankow, James

    • Detection of Undiagnosed Diabetes and Other Hyperglycemia States: The Atherosclerosis Risk in Communities Study Diabetes Care May 2003 26:1338-1343; doi:10.2337/diacare.26.5.1338

  6. Paolisso, Giuseppe

    • Cytokine Milieu Tends Toward Inflammation in Type 2 Diabetes Diabetes Care May 2003 26:1647; doi:10.2337/diacare.26.5.1647

  7. Parving, Hans-Henrik

    • Long-Term Renoprotective Effects of Losartan in Diabetic Nephropathy: Interaction with ACE insertion/deletion genotype? Diabetes Care May 2003 26:1501-1506; doi:10.2337/diacare.26.5.1501

  8. Pearson, Jerusha A.

    • Modem Transmission of Glucose Values Reduces the Costs and Need for Clinic Visits Diabetes Care May 2003 26:1475-1479; doi:10.2337/diacare.26.5.1475

  9. Pearson, William S.

    • C-Reactive Protein and Glycemic Control in Adults With Diabetes Diabetes Care May 2003 26:1535-1539; doi:10.2337/diacare.26.5.1535

  10. Penninx, Brenda W.J.H.

    • Visceral Adipose Tissue Cutoffs Associated With Metabolic Risk Factors for Coronary Heart Disease in Women Diabetes Care May 2003 26:1413-1420; doi:10.2337/diacare.26.5.1413

  11. Perret, Bertrand

    • Differential Levels of γ-Glutamyl Transferase Activity and Apolipoprotein CIII in Men on Either Statin or Fibrate Therapy Diabetes Care May 2003 26:1652-1653; doi:10.2337/diacare.26.5.1652

  12. Perry, Les

    • Low IGF-I and Elevated Testosterone During Puberty in Subjects With Type 1 Diabetes Developing Microalbuminuria in Comparison to Normoalbuminuric Control Subjects: The Oxford Regional Prospective Study Diabetes Care May 2003 26:1456-1461; doi:10.2337/diacare.26.5.1456

  13. Peters, John R.

    • Effect of 2-Week Treatment With Pirenzepine on Fasting and Postprandial Glucose Concentrations in Individuals With Type 2 Diabetes Diabetes Care May 2003 26:1636-1637; doi:10.2337/diacare.26.5.1636

  14. Petit, Jean-Michel

    • Cell Surface Expression of LDL Receptor Is Decreased in Type 2 Diabetic Patients and Is Normalized by Insulin Therapy Diabetes Care May 2003 26:1540-1544; doi:10.2337/diacare.26.5.1540

  15. Pinach, Silvia

    • Prevalence of Type 1 Diabetes-Related Autoantibodies in Adults With Celiac Disease Diabetes Care May 2003 26:1644-1645; doi:10.2337/diacare.26.5.1644

  16. Pitocco, Dario

    • IGF-1 and Macrovascular Complications of Diabetes: Alternative interpretations of recently published data Diabetes Care May 2003 26:1653-1654; doi:10.2337/diacare.26.5.1653

  17. Porcellati, Francesca

    • Intensive Replacement of Basal Insulin in Patients With Type 1 Diabetes Given Rapid-Acting Insulin Analog at Mealtime: A 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime Diabetes Care May 2003 26:1490-1496; doi:10.2337/diacare.26.5.1490

  18. Portnoi, Galina

    • Transfer of Insulin Lispro Across the Human Placenta: In vitro perfusion studies Diabetes Care May 2003 26:1390-1394; doi:10.2337/diacare.26.5.1390

  19. Pouwels, Marie-Jose J.

    • Improved Insulin Sensitivity and Metabolic Control in Type 2 Diabetes Does Not Influence Plasma Homocysteine Diabetes Care May 2003 26:1637-1639; doi:10.2337/diacare.26.5.1637

  20. Premawardhana, Lakdasa D.K.E.

    • Effect of 2-Week Treatment With Pirenzepine on Fasting and Postprandial Glucose Concentrations in Individuals With Type 2 Diabetes Diabetes Care May 2003 26:1636-1637; doi:10.2337/diacare.26.5.1636

  21. Prochaska, James O.

    • Stages of Change for Healthy Eating in Diabetes: Relation to demographic, eating-related, health care utilization, and psychosocial factors Diabetes Care May 2003 26:1468-1474; doi:10.2337/diacare.26.5.1468

R

  1. Radhakrishnan, Jai

    • Analysis of Metabolic Parameters as Predictors of Risk in the RENAAL Study Diabetes Care May 2003 26:1402-1407; doi:10.2337/diacare.26.5.1402

  2. Ramachandran, Ambady

    • Cutoff Values for Normal Anthropometric Variables in Asian Indian Adults Diabetes Care May 2003 26:1380-1384; doi:10.2337/diacare.26.5.1380

  3. Ramot, Yoram

    • Effect of Acute Psychotic Stress in Nondiabetic Subjects on β-Cell Function and Insulin Sensitivity Diabetes Care May 2003 26:1462-1467; doi:10.2337/diacare.26.5.1462

  4. Rapoport, Micha J.

    • Effect of Acute Psychotic Stress in Nondiabetic Subjects on β-Cell Function and Insulin Sensitivity Diabetes Care May 2003 26:1462-1467; doi:10.2337/diacare.26.5.1462

  5. Rewers, Marian J.

    • Differences in LDL Oxidizability by Glycemic Status: The Insulin Resistance Atherosclerosis Study Diabetes Care May 2003 26:1449-1455; doi:10.2337/diacare.26.5.1449

  6. Ricart, Wifredo

    • Insulin Resistance, Inflammation, and Serum Fatty Acid Composition Diabetes Care May 2003 26:1362-1368; doi:10.2337/diacare.26.5.1362

  7. Ricart, Wilfredo

    • The Relation Between Physical Activity and Metabolic Control in Type 2 Diabetes With <20 Years of Evolution Diabetes Care May 2003 26:1648-1650; doi:10.2337/diacare.26.5.1648

  8. Rich, Phoebe

    • Dermatophyte Test Medium Culture for Evaluating Toenail Infections in Patients With Diabetes Diabetes Care May 2003 26:1480-1484; doi:10.2337/diacare.26.5.1480

  9. Rizza, Robert A.

    • A Model to Determine Workforce Needs for Endocrinologists in the United States Until 2020 Diabetes Care May 2003 26:1545-1552; doi:10.2337/diacare.26.5.1545

  10. Roberts, Mary D.

    • Modem Transmission of Glucose Values Reduces the Costs and Need for Clinic Visits Diabetes Care May 2003 26:1475-1479; doi:10.2337/diacare.26.5.1475

  11. Robins, Sander J.

    • Insulin Resistance and Cardiovascular Events With Low HDL Cholesterol: The Veterans Affairs HDL Intervention Trial (VA-HIT) Diabetes Care May 2003 26:1513-1517; doi:10.2337/diacare.26.5.1513

  12. Rodbard, Helena W.

    • A Model to Determine Workforce Needs for Endocrinologists in the United States Until 2020 Diabetes Care May 2003 26:1545-1552; doi:10.2337/diacare.26.5.1545

  13. Rojas, Rosalba

    • Analysis of the Agreement Between the World Health Organization Criteria and the National Cholesterol Education Program-III Definition of the Metabolic Syndrome: Results from a population-based survey Diabetes Care May 2003 26:1635; doi:10.2337/diacare.26.5.1635

  14. Rossetti, Paolo

    • Intensive Replacement of Basal Insulin in Patients With Type 1 Diabetes Given Rapid-Acting Insulin Analog at Mealtime: A 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime Diabetes Care May 2003 26:1490-1496; doi:10.2337/diacare.26.5.1490

  15. Rossi, Antonello

    • The Significance of Impaired Fasting Glucose Versus Impaired Glucose Tolerance: Importance of insulin secretion and resistance Diabetes Care May 2003 26:1333-1337; doi:10.2337/diacare.26.5.1333

  16. Rossi, Joseph S.

    • Stages of Change for Healthy Eating in Diabetes: Relation to demographic, eating-related, health care utilization, and psychosocial factors Diabetes Care May 2003 26:1468-1474; doi:10.2337/diacare.26.5.1468

  17. Rossi, Susan

    • Stages of Change for Healthy Eating in Diabetes: Relation to demographic, eating-related, health care utilization, and psychosocial factors Diabetes Care May 2003 26:1468-1474; doi:10.2337/diacare.26.5.1468

  18. Rossing, Peter

    • Long-Term Renoprotective Effects of Losartan in Diabetic Nephropathy: Interaction with ACE insertion/deletion genotype? Diabetes Care May 2003 26:1501-1506; doi:10.2337/diacare.26.5.1501

  19. Roze, Stéphane

    • A Multivariate Logistic Regression Equation to Screen for Diabetes: Response to Tabaei and Herman Diabetes Care May 2003 26:1658-1659; doi:10.2337/diacare.26.5.1658

  20. Rubins, Hanna Bloomfield

    • Insulin Resistance and Cardiovascular Events With Low HDL Cholesterol: The Veterans Affairs HDL Intervention Trial (VA-HIT) Diabetes Care May 2003 26:1513-1517; doi:10.2337/diacare.26.5.1513

  21. Ruggiero, Laurie

    • Stages of Change for Healthy Eating in Diabetes: Relation to demographic, eating-related, health care utilization, and psychosocial factors Diabetes Care May 2003 26:1468-1474; doi:10.2337/diacare.26.5.1468

  22. Ruidavets, Jean-Bernard

    • Differential Levels of γ-Glutamyl Transferase Activity and Apolipoprotein CIII in Men on Either Statin or Fibrate Therapy Diabetes Care May 2003 26:1652-1653; doi:10.2337/diacare.26.5.1652

  23. Rull, Juan A.

    • Analysis of the Agreement Between the World Health Organization Criteria and the National Cholesterol Education Program-III Definition of the Metabolic Syndrome: Results from a population-based survey Diabetes Care May 2003 26:1635; doi:10.2337/diacare.26.5.1635

  24. Ryan, Alice S.

    • Visceral Adipose Tissue Cutoffs Associated With Metabolic Risk Factors for Coronary Heart Disease in Women Diabetes Care May 2003 26:1413-1420; doi:10.2337/diacare.26.5.1413

  25. Ríos-Torres, Juan Manuel

    • Analysis of the Agreement Between the World Health Organization Criteria and the National Cholesterol Education Program-III Definition of the Metabolic Syndrome: Results from a population-based survey Diabetes Care May 2003 26:1635; doi:10.2337/diacare.26.5.1635

S

  1. Sabatini, Andrea

    • Effects of an Automated Electronic Reminder in Changing the Antiplatelet Drug–Prescribing Behavior Among Italian General Practitioners in Diabetic Patients: An intervention trial Diabetes Care May 2003 26:1497-1500; doi:10.2337/diacare.26.5.1497

  2. Sainaghi, Pier Paolo

    • The Significance of Impaired Fasting Glucose Versus Impaired Glucose Tolerance: Importance of insulin secretion and resistance Diabetes Care May 2003 26:1333-1337; doi:10.2337/diacare.26.5.1333

  3. Sakai, Naohiko

    • Lipoprotein Abnormalities in Human Genetic CD36 Deficiency Associated With Insulin Resistance and Abnormal Fatty Acid Metabolism Diabetes Care May 2003 26:1647-1648; doi:10.2337/diacare.26.5.1647-a

  4. Sakakida, Michiharu

    • Evaluation of Urinary 8-Hydroxydeoxy-Guanosine as a Novel Biomarker of Macrovascular Complications in Type 2 Diabetes Diabetes Care May 2003 26:1507-1512; doi:10.2337/diacare.26.5.1507

  5. Salazar, Holger

    • Association of Hypoglycemia and Cardiac Ischemia: A study based on continuous monitoring Diabetes Care May 2003 26:1485-1489; doi:10.2337/diacare.26.5.1485

  6. Samani, Fabio

    • Effects of an Automated Electronic Reminder in Changing the Antiplatelet Drug–Prescribing Behavior Among Italian General Practitioners in Diabetic Patients: An intervention trial Diabetes Care May 2003 26:1497-1500; doi:10.2337/diacare.26.5.1497

  7. Sasahara, Takayuki

    • Evaluation of Urinary 8-Hydroxydeoxy-Guanosine as a Novel Biomarker of Macrovascular Complications in Type 2 Diabetes Diabetes Care May 2003 26:1507-1512; doi:10.2337/diacare.26.5.1507

  8. Sattar, Naveed

    • Prospective Relation of C-Reactive Protein With Type 2 Diabetes: Response to Snijder et al. Diabetes Care May 2003 26:1657-1658; doi:10.2337/diacare.26.5.1657

  9. Saudek, Christopher D.

  10. Scanlon, Maurice F.

    • Effect of 2-Week Treatment With Pirenzepine on Fasting and Postprandial Glucose Concentrations in Individuals With Type 2 Diabetes Diabetes Care May 2003 26:1636-1637; doi:10.2337/diacare.26.5.1636

  11. Schaefer, Ernst J.

    • Insulin Resistance and Cardiovascular Events With Low HDL Cholesterol: The Veterans Affairs HDL Intervention Trial (VA-HIT) Diabetes Care May 2003 26:1513-1517; doi:10.2337/diacare.26.5.1513

  12. Schenck, Anna P.

    • Lipid Testing Among Patients With Diabetes Who Receive Diabetes Care From Primary Care Physicians Diabetes Care May 2003 26:1369-1373; doi:10.2337/diacare.26.5.1369

  13. Schmidt, Maria Inês

    • Detection of Undiagnosed Diabetes and Other Hyperglycemia States: The Atherosclerosis Risk in Communities Study Diabetes Care May 2003 26:1338-1343; doi:10.2337/diacare.26.5.1338

  14. Schultz, Carl

    • Low IGF-I and Elevated Testosterone During Puberty in Subjects With Type 1 Diabetes Developing Microalbuminuria in Comparison to Normoalbuminuric Control Subjects: The Oxford Regional Prospective Study Diabetes Care May 2003 26:1456-1461; doi:10.2337/diacare.26.5.1456

  15. Schwenke, Dawn C.

    • Differences in LDL Oxidizability by Glycemic Status: The Insulin Resistance Atherosclerosis Study Diabetes Care May 2003 26:1449-1455; doi:10.2337/diacare.26.5.1449

  16. Scionti, Luciano

    • Intensive Replacement of Basal Insulin in Patients With Type 1 Diabetes Given Rapid-Acting Insulin Analog at Mealtime: A 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime Diabetes Care May 2003 26:1490-1496; doi:10.2337/diacare.26.5.1490

  17. Seidell, Jacob C.

    • Prospective Relation of C-Reactive Protein With Type 2 Diabetes: Response to Han et al. Diabetes Care May 2003 26:1656-1657; doi:10.2337/diacare.26.5.1656

  18. Semler, Andrea J.

    • Fibrinogen Is a Marker for Nephropathy and Peripheral Vascular Disease in Type 1 Diabetes: Studies of plasma fibrinogen and fibrinogen gene polymorphism in the DCCT/EDIC cohort Diabetes Care May 2003 26:1439-1448; doi:10.2337/diacare.26.5.1439

  19. Senokuchi, Takahumi

    • Evaluation of Urinary 8-Hydroxydeoxy-Guanosine as a Novel Biomarker of Macrovascular Complications in Type 2 Diabetes Diabetes Care May 2003 26:1507-1512; doi:10.2337/diacare.26.5.1507

  20. Sepulveda, Jaime

    • Analysis of the Agreement Between the World Health Organization Criteria and the National Cholesterol Education Program-III Definition of the Metabolic Syndrome: Results from a population-based survey Diabetes Care May 2003 26:1635; doi:10.2337/diacare.26.5.1635

  21. Shahinfar, Shahnaz

    • Analysis of Metabolic Parameters as Predictors of Risk in the RENAAL Study Diabetes Care May 2003 26:1402-1407; doi:10.2337/diacare.26.5.1402

  22. Shiloah, Eli

    • Effect of Acute Psychotic Stress in Nondiabetic Subjects on β-Cell Function and Insulin Sensitivity Diabetes Care May 2003 26:1462-1467; doi:10.2337/diacare.26.5.1462

  23. Shintani, Ayumi

    • Glycemic Relapse After an Intensive Outpatient Intervention for Type 2 Diabetes Diabetes Care May 2003 26:1645-1646; doi:10.2337/diacare.26.5.1645

  24. Shoji, Shin’ichi

    • Laughter Lowered the Increase in Postprandial Blood Glucose Diabetes Care May 2003 26:1651-1652; doi:10.2337/diacare.26.5.1651

  25. Shoji, Tetsuo

    • Factors Affecting Progression of Renal Failure in Patients With Type 2 Diabetes Diabetes Care May 2003 26:1530-1534; doi:10.2337/diacare.26.5.1530

  26. Simpson, Ross J.

    • Lipid Testing Among Patients With Diabetes Who Receive Diabetes Care From Primary Care Physicians Diabetes Care May 2003 26:1369-1373; doi:10.2337/diacare.26.5.1369

  27. Singer, Daniel E.

    • Polypharmacy and Medication Adherence in Patients With Type 2 Diabetes Diabetes Care May 2003 26:1408-1412; doi:10.2337/diacare.26.5.1408

  28. Singh, Maria A. Fiatarone

    • Battling Insulin Resistance in Elderly Obese People With Type 2 Diabetes: Bring on the heavy weights Diabetes Care May 2003 26:1580-1588; doi:10.2337/diacare.26.5.1580

  29. Smithline Kinder, Leslie

    • Insulin Resistance–Related Factors, but not Glycemia, Predict Coronary Artery Disease in Type 1 Diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications study Diabetes Care May 2003 26:1374-1379; doi:10.2337/diacare.26.5.1374

  30. Snehalatha, Chamukuttan

    • Cutoff Values for Normal Anthropometric Variables in Asian Indian Adults Diabetes Care May 2003 26:1380-1384; doi:10.2337/diacare.26.5.1380

  31. Snetselaar, Linda

    • Stages of Change and Eating Behaviors: Issues on categorizing Diabetes Care May 2003 26:1624-1625; doi:10.2337/diacare.26.5.1624

  32. Snijder, Marieke B.

    • Prospective Relation of C-Reactive Protein With Type 2 Diabetes: Response to Han et al. Diabetes Care May 2003 26:1656-1657; doi:10.2337/diacare.26.5.1656

  33. Sobel, Burton E.

    • Coronary Disease in Type 1 Diabetes: Causal contiguity and clinical implications Diabetes Care May 2003 26:1629-1630; doi:10.2337/diacare.26.5.1629

  34. Sonoda, Kazuhiro

    • Evaluation of Urinary 8-Hydroxydeoxy-Guanosine as a Novel Biomarker of Macrovascular Complications in Type 2 Diabetes Diabetes Care May 2003 26:1507-1512; doi:10.2337/diacare.26.5.1507

  35. Stehouwer, Coen D.A.

    • Prospective Relation of C-Reactive Protein With Type 2 Diabetes: Response to Han et al. Diabetes Care May 2003 26:1656-1657; doi:10.2337/diacare.26.5.1656

  36. Stryer, Daniel

  37. Sumida, Yasuhiro

    • Increased Oxidative Stress Is Associated With Elevated Plasma Levels of Adrenomedullin in Hypertensive Patients With Type 2 Diabetes Diabetes Care May 2003 26:1642-1643; doi:10.2337/diacare.26.5.1642

  38. Surks, Martin I.

    • A Model to Determine Workforce Needs for Endocrinologists in the United States Until 2020 Diabetes Care May 2003 26:1545-1552; doi:10.2337/diacare.26.5.1545

T

  1. Tabaei, Bahman P.

    • A Multivariate Logistic Regression Equation to Screen for Diabetes: Response to Roze, Palmer, and Valentine Diabetes Care May 2003 26:1659; doi:10.2337/diacare.26.5.1659

  2. Tack, Cees J.

    • Improved Insulin Sensitivity and Metabolic Control in Type 2 Diabetes Does Not Influence Plasma Homocysteine Diabetes Care May 2003 26:1637-1639; doi:10.2337/diacare.26.5.1637

  3. Tandon, Puneeta

    • Diabetes and Coronary Artery Bypass Surgery: An examination of perioperative glycemic control and outcomes Diabetes Care May 2003 26:1518-1524; doi:10.2337/diacare.26.5.1518

  4. Tarnow, Lise

    • Long-Term Renoprotective Effects of Losartan in Diabetic Nephropathy: Interaction with ACE insertion/deletion genotype? Diabetes Care May 2003 26:1501-1506; doi:10.2337/diacare.26.5.1501

  5. Taskinen, Marja-Riitta

    • IGF Binding Protein-1 and Carotid Intima-Media Thickness in Type 2 Diabetes: Response to Conti et al. Diabetes Care May 2003 26:1654-1655; doi:10.2337/diacare.26.5.1654

  6. Tate, Philip W.

    • Metformin in Type 1 Diabetes: Is this a good or bad idea? Diabetes Care May 2003 26:1655; doi:10.2337/diacare.26.5.1655

  7. Thomas, G. Neil

    • Renin-Angiotensin System Gene Polymorphisms and Retinopathy in Chinese Patients With Type 2 Diabetes Diabetes Care May 2003 26:1643-1644; doi:10.2337/diacare.26.5.1643

  8. Tomlinson, Brian

    • Renin-Angiotensin System Gene Polymorphisms and Retinopathy in Chinese Patients With Type 2 Diabetes Diabetes Care May 2003 26:1643-1644; doi:10.2337/diacare.26.5.1643

  9. Torlone, Elisabetta

    • Intensive Replacement of Basal Insulin in Patients With Type 1 Diabetes Given Rapid-Acting Insulin Analog at Mealtime: A 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime Diabetes Care May 2003 26:1490-1496; doi:10.2337/diacare.26.5.1490

  10. Tredwell, Jeffrey

    • Diabetic Foot Syndrome: Evaluating the prevalence and incidence of foot pathology in Mexican Americans and non-Hispanic whites from a diabetes disease management cohort Diabetes Care May 2003 26:1435-1438; doi:10.2337/diacare.26.5.1435

  11. Tripathy, Devjit

    • Importance of Obtaining Independent Measures of Insulin Secretion and Insulin Sensitivity During the Same Test: Results with the Botnia clamp Diabetes Care May 2003 26:1395-1401; doi:10.2337/diacare.26.5.1395

  12. Tu, Jack V.

    • Processes and Outcomes of Care for Diabetic Acute Myocardial Infarction Patients in Ontario: Do physicians undertreat? Diabetes Care May 2003 26:1427-1434; doi:10.2337/diacare.26.5.1427

  13. Tuomi, Tiinamaija

    • Importance of Obtaining Independent Measures of Insulin Secretion and Insulin Sensitivity During the Same Test: Results with the Botnia clamp Diabetes Care May 2003 26:1395-1401; doi:10.2337/diacare.26.5.1395

U

  1. Uccioli, Luigi

    • Contribution of Plantar Fascia to the Increased Forefoot Pressures in Diabetic Patients Diabetes Care May 2003 26:1525-1529; doi:10.2337/diacare.26.5.1525

  2. Ueda, Hideki

    • Factors Affecting Progression of Renal Failure in Patients With Type 2 Diabetes Diabetes Care May 2003 26:1530-1534; doi:10.2337/diacare.26.5.1530

  3. Unger, Abraham

    • Effect of Acute Psychotic Stress in Nondiabetic Subjects on β-Cell Function and Insulin Sensitivity Diabetes Care May 2003 26:1462-1467; doi:10.2337/diacare.26.5.1462

  4. Urakawa, Hideki

    • Increased Oxidative Stress Is Associated With Elevated Plasma Levels of Adrenomedullin in Hypertensive Patients With Type 2 Diabetes Diabetes Care May 2003 26:1642-1643; doi:10.2337/diacare.26.5.1642

V

  1. Valentine, William J.

    • A Multivariate Logistic Regression Equation to Screen for Diabetes: Response to Tabaei and Herman Diabetes Care May 2003 26:1658-1659; doi:10.2337/diacare.26.5.1658

  2. Valles, Victoria

    • Analysis of the Agreement Between the World Health Organization Criteria and the National Cholesterol Education Program-III Definition of the Metabolic Syndrome: Results from a population-based survey Diabetes Care May 2003 26:1635; doi:10.2337/diacare.26.5.1635

  3. Vallis, Michael

    • Stages of Change for Healthy Eating in Diabetes: Relation to demographic, eating-related, health care utilization, and psychosocial factors Diabetes Care May 2003 26:1468-1474; doi:10.2337/diacare.26.5.1468

  4. Vendrell, Joan

    • Insulin Resistance, Inflammation, and Serum Fatty Acid Composition Diabetes Care May 2003 26:1362-1368; doi:10.2337/diacare.26.5.1362

  5. Vergès, Bruno

    • Cell Surface Expression of LDL Receptor Is Decreased in Type 2 Diabetic Patients and Is Normalized by Insulin Therapy Diabetes Care May 2003 26:1540-1544; doi:10.2337/diacare.26.5.1540

  6. Vigersky, Robert A.

    • A Model to Determine Workforce Needs for Endocrinologists in the United States Until 2020 Diabetes Care May 2003 26:1545-1552; doi:10.2337/diacare.26.5.1545

  7. Vigo, Alvaro

    • Detection of Undiagnosed Diabetes and Other Hyperglycemia States: The Atherosclerosis Risk in Communities Study Diabetes Care May 2003 26:1338-1343; doi:10.2337/diacare.26.5.1338

  8. Vinik, Aaron I.

  9. Visser, Marjolein

    • Prospective Relation of C-Reactive Protein With Type 2 Diabetes: Response to Han et al. Diabetes Care May 2003 26:1656-1657; doi:10.2337/diacare.26.5.1656

  10. Viswanathan, Vijay

    • Cutoff Values for Normal Anthropometric Variables in Asian Indian Adults Diabetes Care May 2003 26:1380-1384; doi:10.2337/diacare.26.5.1380

  11. van Haeften, Timon W.

    • β2-Adrenergic Receptor Polymorphism and Obesity in Type 2 Diabetes: Response to Yoshioka, Yoshida, and Yoshikawa Diabetes Care May 2003 26:1659-1660; doi:10.2337/diacare.26.5.1659-b

  12. van Tilburg, Jonathan H.

    • β2-Adrenergic Receptor Polymorphism and Obesity in Type 2 Diabetes: Response to Yoshioka, Yoshida, and Yoshikawa Diabetes Care May 2003 26:1659-1660; doi:10.2337/diacare.26.5.1659-b

W

  1. Wagenknecht, Lynne E.

    • Differences in LDL Oxidizability by Glycemic Status: The Insulin Resistance Atherosclerosis Study Diabetes Care May 2003 26:1449-1455; doi:10.2337/diacare.26.5.1449

  2. Wake, Nakayasu

    • Evaluation of Urinary 8-Hydroxydeoxy-Guanosine as a Novel Biomarker of Macrovascular Complications in Type 2 Diabetes Diabetes Care May 2003 26:1507-1512; doi:10.2337/diacare.26.5.1507

  3. Weiss, Mordechai

    • Effect of Acute Psychotic Stress in Nondiabetic Subjects on β-Cell Function and Insulin Sensitivity Diabetes Care May 2003 26:1462-1467; doi:10.2337/diacare.26.5.1462

  4. Weller, Wendy E.

  5. Wessman, Ylva

    • Importance of Obtaining Independent Measures of Insulin Secretion and Insulin Sensitivity During the Same Test: Results with the Botnia clamp Diabetes Care May 2003 26:1395-1401; doi:10.2337/diacare.26.5.1395

  6. Westergaard, Jes G.

    • Audit on Stillbirths in Women With Pregestational Type 1 Diabetes Diabetes Care May 2003 26:1385-1389; doi:10.2337/diacare.26.5.1385

  7. Wightman, Clare

    • Modem Transmission of Glucose Values Reduces the Costs and Need for Clinic Visits Diabetes Care May 2003 26:1475-1479; doi:10.2337/diacare.26.5.1475

  8. Wijmenga, Cisca

    • β2-Adrenergic Receptor Polymorphism and Obesity in Type 2 Diabetes: Response to Yoshioka, Yoshida, and Yoshikawa Diabetes Care May 2003 26:1659-1660; doi:10.2337/diacare.26.5.1659-b

  9. Wilder, Ronald P.

  10. Willey, Karen A.

    • Battling Insulin Resistance in Elderly Obese People With Type 2 Diabetes: Bring on the heavy weights Diabetes Care May 2003 26:1580-1588; doi:10.2337/diacare.26.5.1580

  11. Williams, Katherine

    • Insulin Resistance–Related Factors, but not Glycemia, Predict Coronary Artery Disease in Type 1 Diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications study Diabetes Care May 2003 26:1374-1379; doi:10.2337/diacare.26.5.1374

  12. Williams, Ken

    • Prospective Relation of C-Reactive Protein With Type 2 Diabetes: Response to Snijder et al. Diabetes Care May 2003 26:1657-1658; doi:10.2337/diacare.26.5.1657

  13. Wiltshire, Esko J.

    • Dietary Fats Do Not Contribute to Hyperlipidemia in Children and Adolescents With Type 1 Diabetes Diabetes Care May 2003 26:1356-1361; doi:10.2337/diacare.26.5.1356

  14. Witz, Shula

    • Effect of Acute Psychotic Stress in Nondiabetic Subjects on β-Cell Function and Insulin Sensitivity Diabetes Care May 2003 26:1462-1467; doi:10.2337/diacare.26.5.1462

  15. Wolff, Kathleen

    • Glycemic Relapse After an Intensive Outpatient Intervention for Type 2 Diabetes Diabetes Care May 2003 26:1645-1646; doi:10.2337/diacare.26.5.1645

  16. Wu, Albert W.

  17. Wunderlich, Robert P.

    • Diabetic Foot Syndrome: Evaluating the prevalence and incidence of foot pathology in Mexican Americans and non-Hispanic whites from a diabetes disease management cohort Diabetes Care May 2003 26:1435-1438; doi:10.2337/diacare.26.5.1435

Y

  1. Yakub, Mohamed Janabi

    • Lipoprotein Abnormalities in Human Genetic CD36 Deficiency Associated With Insulin Resistance and Abnormal Fatty Acid Metabolism Diabetes Care May 2003 26:1647-1648; doi:10.2337/diacare.26.5.1647-a

  2. Yamashita, Shizuya

    • Lipoprotein Abnormalities in Human Genetic CD36 Deficiency Associated With Insulin Resistance and Abnormal Fatty Acid Metabolism Diabetes Care May 2003 26:1647-1648; doi:10.2337/diacare.26.5.1647-a

  3. Yamauchi-Takihara, Keiko

    • Lipoprotein Abnormalities in Human Genetic CD36 Deficiency Associated With Insulin Resistance and Abnormal Fatty Acid Metabolism Diabetes Care May 2003 26:1647-1648; doi:10.2337/diacare.26.5.1647-a

  4. Yang, Jianmei

    • HLA-DR-DQ Haplotype in Rapid-Onset Type 1 Diabetes in Japanese Diabetes Care May 2003 26:1640-1641; doi:10.2337/diacare.26.5.1640

  5. Yano, Yutaka

    • Increased Oxidative Stress Is Associated With Elevated Plasma Levels of Adrenomedullin in Hypertensive Patients With Type 2 Diabetes Diabetes Care May 2003 26:1642-1643; doi:10.2337/diacare.26.5.1642

  6. Yatagai, Toshimitsu

    • HLA-DR-DQ Haplotype in Rapid-Onset Type 1 Diabetes in Japanese Diabetes Care May 2003 26:1640-1641; doi:10.2337/diacare.26.5.1640

  7. Yeung, Vincent T.F.

    • Renin-Angiotensin System Gene Polymorphisms and Retinopathy in Chinese Patients With Type 2 Diabetes Diabetes Care May 2003 26:1643-1644; doi:10.2337/diacare.26.5.1643

  8. Yoshida, Toshihide

    • β2-Adrenergic Receptor Polymorphism and Obesity in Type 2 Diabetes: Response to van Tilburg et al. Diabetes Care May 2003 26:1659; doi:10.2337/diacare.26.5.1659-a

  9. Yoshikawa, Toshikazu

    • β2-Adrenergic Receptor Polymorphism and Obesity in Type 2 Diabetes: Response to van Tilburg et al. Diabetes Care May 2003 26:1659; doi:10.2337/diacare.26.5.1659-a

  10. Yoshioka, Keiji

    • β2-Adrenergic Receptor Polymorphism and Obesity in Type 2 Diabetes: Response to van Tilburg et al. Diabetes Care May 2003 26:1659; doi:10.2337/diacare.26.5.1659-a

  11. Young, William F.

    • A Model to Determine Workforce Needs for Endocrinologists in the United States Until 2020 Diabetes Care May 2003 26:1545-1552; doi:10.2337/diacare.26.5.1545

  12. Yudkin, John S.

    • Prospective Relation of C-Reactive Protein With Type 2 Diabetes: Response to Han et al. Diabetes Care May 2003 26:1656-1657; doi:10.2337/diacare.26.5.1656

Z

  1. Zheng, Deyi

    • Fibrinogen Is a Marker for Nephropathy and Peripheral Vascular Disease in Type 1 Diabetes: Studies of plasma fibrinogen and fibrinogen gene polymorphism in the DCCT/EDIC cohort Diabetes Care May 2003 26:1439-1448; doi:10.2337/diacare.26.5.1439

  2. Zinman, Bernard

    • Stages of Change for Healthy Eating in Diabetes: Relation to demographic, eating-related, health care utilization, and psychosocial factors Diabetes Care May 2003 26:1468-1474; doi:10.2337/diacare.26.5.1468

  3. Zuppi, Cecilia

    • IGF-1 and Macrovascular Complications of Diabetes: Alternative interpretations of recently published data Diabetes Care May 2003 26:1653-1654; doi:10.2337/diacare.26.5.1653

Ø

  1. Ørskov, Hans

    • Low IGF-I and Elevated Testosterone During Puberty in Subjects With Type 1 Diabetes Developing Microalbuminuria in Comparison to Normoalbuminuric Control Subjects: The Oxford Regional Prospective Study Diabetes Care May 2003 26:1456-1461; doi:10.2337/diacare.26.5.1456

Current Issue

  1. February 2010, 33 (2)
  1. Current Issue
  1. Alert me to new issues of Diabetes Care